Prostate cancer decisions — 2024

The Board has found that new and relevant evidence has been presented to readjudicate the claims for service connection for a heart condition, diabetes, prostate cancer, and a left foot condition. The claims are being remanded for further consideration.

The Board denied the Veteran's claim for service connection for prostate cancer as secondary to prostatitis with dysuria, finding that there is no causal relationship between the conditions.

The Veteran's prostate cancer residuals are granted as service-connected.,Service connection for diabetes mellitus, type II, ischemic heart condition, and hypertension is remanded due to potential exposure to herbicides or chemicals during service.

The Veteran's TDIU claim is granted from March 13, 2019. The effective date for the increased rating of PTSD and the TDIU was changed to August 19, 2019 due to a finding of clear and unmistakable error in the September 2019 decision.

The Board has remanded the claims for prostate condition, hypertension, chronic headaches, ED, GERD, allergic rhinitis, sinusitis, skin condition (melanoma of neck and face), back disability, left ankle injury, right ankle disability, and right shoulder disability due to a duty to assist error.,The Veteran's service connection claims are remanded as the Board finds that VA examinations and medical opinions are required to determine whether these claimed disabilities are etiologically related to his active service or other service-connected conditions.

The Veteran's appeals for service connection for bilateral hearing loss and tinnitus have been dismissed as a matter of law. The appeal for prostate cancer is remanded due to the need for a new medical opinion.

The Board has dismissed the appeal due to the Veteran's passing, and no further action can be taken on these claims.

The Board denied service connection for tinnitus, bilateral hearing loss, diabetes mellitus, ischemic heart disease, prostate cancer, erectile dysfunction, and loss of use the lower extremities as secondary to prostate cancer due to lack of evidence linking these conditions to military service.

The Veteran's appeal for increased ratings for residuals of prostate cancer and bladder cancer has been dismissed as the Veteran requested withdrawal of the appeal.

The Veteran's prostate cancer residuals are rated at 40 percent, and the Board has denied a rating in excess of this amount.

The Veteran's claims for service connection for coronary artery disease, hypertension, and prostate cancer are being remanded due to pre-decisional errors in VA's duty to assist. The AOJ is instructed to obtain additional medical opinions regarding the relationship between these conditions and the Veteran's exposure as an automotive mechanic.

The Board has remanded the case due to a pre-decisional duty to assist error, requiring further development and consideration of whether prostate cancer and/or radiation treatment therefor was a principal or contributory cause of death by ischemic bowel/colitis, and whether renal cell carcinoma is etiologically related to active service.

The Board has remanded the case due to a need for an addendum opinion regarding the relationship between the Veteran's prostate cancer and his chemical exposures during service, including exposure to contaminated groundwater at McClellan Air Force Base.

The Board has remanded the case for a VA examination to determine if the Veteran's hypertension began in service or is otherwise related to service, including elevated blood pressure readings in May 1975. The other claims of service connection are denied.

The Board has decided to remand the case due to a failure to properly consider evidence of herbicide exposure at Fort Chaffee, which could potentially establish service connection for prostate cancer and bladder leakage.

The Veteran's prostate cancer and erectile dysfunction have been granted service connection, effective August 10, 2022.,An initial evaluation of 100% for prostate cancer is also granted.

The Board has decided to remand the case due to inadequate medical examinations and scheduling errors, specifically regarding the Veteran's prostate cancer residuals.

The Board denied the Veteran's claim for service connection for prostate cancer as there was no evidence of herbicide agent exposure during his military service in Korea.

The Veteran's appeal for increased ratings for residuals of prostate cancer and bladder cancer has been dismissed as the Veteran requested withdrawal of the appeal.

The Veteran's appeal includes requests for increased ratings for prostate cancer and a separate issue regarding multiple, noncompensable service-connected disabilities. The Board has determined that additional evidence is needed to fully consider the prostate cancer claim.